Clinical trials
Observational Acquired Immunodeficiency Syndrome trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2015 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Unknown status | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| UPECLIN HC FM Botucatu Unesp | 2 |
| Federal University of São Paulo | 1 |
| Hospital Alemão Oswaldo Cruz | 1 |
| Kirby Institute | 1 |
| National Cancer Institute (NCI) | 1 |
| Oswaldo Cruz Foundation | 1 |
| The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 1 |
| Universidade Federal de Goias | 1 |
| University Paris 7 - Denis Diderot | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 14 |
| HIV Infections | 4 |
| Hepatitis C | 3 |
| Neoplasms | 2 |
| COVID-19 | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cardiovascular Diseases | 1 |
| Cerebrovascular Disorders | 1 |
| Coronavirus Infections | 1 |
| Disease | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.